Here you can find news from MPG spin-off companies.
MorphoSys and Incyte Announce Swissmedic Temporary Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with r/r DLBCL
Evotec receives € 3 m milestone payment for Bayer starting Phase II clinical development of DNP programme
Alnylam Pharmaceuticals Files Patent Infringement Suits against Pfizer and Moderna
Alnylam Announces U.S. Food and Drug Administration Acceptance of Supplemental New Drug Application for OXLUMO® for the Treatment of Advanced Primary Hyperoxaluria Type 1
Evotec participates in Centauri Therapeutics' Series A investment round